Companies / Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc.

Nasdaq: ACRVCIK 1781174WATERTOWN, MA

Financials

Revenue—
Net income$-77.91M
Total debt—
Cash$41.42M
Diluted EPS$-2.02
Shares outstanding42.9M

Ownership

42.9M shares outstanding · as of Aug 7, 2026
6.0%Insiders
Ownership
Insiders5.98%2,561,128
Institutions24.87%10,656,742
Public float69.16%29,635,492

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Blume-Jensen PeterCEOPresident and CEO · Director
5.59%2,394,331
Devroe EricChief Operating Officer
0.17%74,585
Miller MaryChief Legal Officer
0.08%33,679
Levy Adam D.Chief Financial Officer
0.05%20,983
Gamelin ErickChief Development Officer
0.03%14,812
Magovcevic-Liebisch IvanaDirector
0.02%9,366
RA Capital Management, L.P.Director · 10% owner
0.02%9,366
Peterson KatharineChief Accounting Officer
<0.01%4,006
Kolchinsky PeterDirector · 10% owner
——
Masson KristinaEVP - Business Operations · Director
——

Institutional holders 50

View all →
HolderValue% of shares
RA Capital Management, L.P.$11.59M19.46%
Sands Capital Alternatives, LLC$5.12M4.95%
Citadel Advisors LLC$3.96M3.83%
Wellington Management Group LLP$2.14M2.07%
Vanguard Group Inc$1.68M1.63%
Renaissance Technologies LLC$1.05M1.77%
Acorn Capital Advisors, LLC$976.6K0.95%
UBS Group AG$840.0K0.81%
Jane Street Group, LLC$824.4K0.80%
Two Sigma Advisers, LP$804.4K0.78%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 22, 2026RA Capital Management, L.P.
Director
GrantCommon Stock$7.00M+3.9M
+49.14%
11,803,094
27.54% of shares
low
Jan 14, 2026Blume-Jensen Peter
CEO
BuyCommon Stock$82.1K+49K
+2.39%
2,095,771
4.89% of shares
medium
Feb 21, 2026Blume-Jensen Peter
CEO
OtherCommon Stock$21.8K-14K
-0.68%
2,080,204
4.85% of shares
low
Jan 13, 2026Devroe Eric
Executive
BuyCommon Stock$17.2K+10K
+15.31%
75,308
0.18% of shares
low
Jan 14, 2026Levy Adam D.
Executive
BuyCommon Stock$15.0K+9K
+72.69%
20,983
0.05% of shares
low
Feb 14, 2026Blume-Jensen Peter
CEO
OtherCommon Stock$2.1K-1K
-0.06%
2,094,469
4.89% of shares
low
Jan 17, 2026Miller Mary
Executive
OtherCommon Stock$1.3K-659
-1.91%
33,896
0.08% of shares
low
Feb 14, 2026Devroe Eric
Executive
OtherCommon Stock$1.2K-723
-0.96%
74,585
0.17% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ACRVCommon StockEquity004890109BBG011RWR2Q4